21 - 30 of 7942 Results
Title
Year
- The effects of chemogenetic targeting of serotonin-projecting pathways on L-DOPA-induced dyskinesia and psychosis in a bilateral rat model of Parkinson’s disease2024OPENTitle: The effects of chemogenetic targeting of serotonin-projecting pathways on L-DOPA-induced dyskinesia and psychosis in a bilateral rat model of Parkinson’s diseaseJournal Name: Frontiers in Neural CircuitsPublisher: Frontiers Media SAVol: 18Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3389/fncir.2024.1463941Citation Count: 0
- PathogenicLRRK2mutations cause loss of primary cilia and Neurturin in striatal parvalbumin interneurons2024OPENTitle: PathogenicLRRK2mutations cause loss of primary cilia and Neurturin in striatal parvalbumin interneuronsJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 8Issue #: 1Start Page: e202402922End Page: e202402922Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.26508/lsa.202402922Citation Count: 0
- Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome‐Wide Association Study2024OPENTitle: Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome‐Wide Association StudyJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.30054Citation Count: 0
- Genetic architecture of cerebrospinal fluid and brain metabolite levels and the genetic colocalization of metabolites with human traits2024RESTRICTEDTitle: Genetic architecture of cerebrospinal fluid and brain metabolite levels and the genetic colocalization of metabolites with human traitsJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 56Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41588-024-01973-7Citation Count: 0
- Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET Radioligand2024OPENTitle: Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET RadioligandJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 15Issue #: 22Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00493Citation Count: 0
- Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease2024RESTRICTEDTitle: Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s diseaseJournal Name: Nature GeneticsPublisher: Springer Science and Business Media LLCVol: 56Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41588-024-01972-8Citation Count: 1
-
OPENTitle: A framework for translational therapy development in deep brain stimulationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00829-5Citation Count: 0
- Novel tools to quantify total, phospho-Ser129 and aggregated alpha-synuclein in the mouse brain2024OPENTitle: Novel tools to quantify total, phospho-Ser129 and aggregated alpha-synuclein in the mouse brainJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00830-yCitation Count: 0
- The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson’s disease2024OPENTitle: The p.Gly2019Ser is a common LRRK2 pathogenic variant among Egyptians with familial and sporadic Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41531-024-00826-8Citation Count: 0
- Systemic inflammation accelerates neurodegeneration in a rat model of Parkinson’s disease overexpressing human alpha synuclein2024OPENTitle: Systemic inflammation accelerates neurodegeneration in a rat model of Parkinson’s disease overexpressing human alpha synucleinJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00824-wCitation Count: 0